Dr. Christopher C. Annunziata, MD

Dr. Annunziata practices at McLean Tysons Orthopedic Surgery Center - HOPD in Mclean, Virginia.

Dr. Annunziata's NPI, 1548287972, was assigned on July 15, 2006. Dr. Annunziata graduated from Georgetown University School Of Medicine in 1994. Dr. Annunziata holds Virginia license 0101225480.

Dr. Annunziata's primary practice is McLean Tysons Orthopedic Surgery Center - HOPD, at 1760 Old Meadow Rd, Mclean, VA 22102.

Dr. Annunziata's primary practice is McLean Tysons Orthopedic Surgery Center - HOPD in Mclean, Virginia. Dr. Annunziata is also affiliated with VHC Health. The medical group on file is OrthoVirginia. Dmand AI also links Dr. Annunziata to 2 more group practices and clinics, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Annunziata practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Annunziata's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Annunziata is board certified in orthopaedic sports medicine by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Annunziata's licenses on file in 3 states: Virginia, Maryland and District of Columbia.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, enthesopathy in arms, fluid in a joint, joint arthropathy, joint cyst and joint or bone infection among the conditions Dr. Annunziata treats.

CMS data shows 1,688 Medicare services from Dr. Annunziata across 10 procedure codes in 2024, for 399 Medicare patients. Medicare paid $118,950 for them.

CMS counts 399 Medicare patients who saw Dr. Annunziata in 2024. The largest group is 65 to 74, with 205 patients. 75% of them have arthritis, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Annunziata's median patient age at 49, with 48% women.

In 2024, Dr. Annunziata wrote 62 Medicare Part D claims for 41 patients. 97% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $147 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Annunziata for performance year 2024, reported as part of a group. Dr. Annunziata accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Annunziata, published from 2017 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Anterior Cruciate Ligament Injuries, Reoperation and Anterior Cruciate Ligament Reconstruction. Dr. Annunziata has published most often in Am J Sports Med. Dr. Annunziata's most frequent co-authors are Robert A. Arciero, MD, Keith M. Baumgarten, MD and Stephen F. Brockmeier, MD.

CMS Open Payments shows 81 general payments to Dr. Annunziata from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. DePuy Synthes Sales Inc. paid the most, $2,879.

Dmand AI lists 2 awards for Dr. Annunziata.

Dr. Annunziata graduated from Georgetown University School Of Medicine in 1994. Dr. Annunziata is a member of AAOS, AOSSM and AANA.

Dr. Annunziata is in network with 18 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.